| Term 
 
        | What are the 4 Antiarrhythmic Classes of Drugs? |  | Definition 
 
        | Class I - Na+ Channel Blockers Class II - Beta Blockers
 Class III - K+ Channel Blockers
 Class IV - Ca++ Channel Blockers
 |  | 
        |  | 
        
        | Term 
 
        | What are the Class I Drugs? |  | Definition 
 
        | Class IA: -Qunidine
 -Procainamide
 -Disopyramide
 Class IB:
 -Lidocaine
 -Mexilitine
 -Tocainide
 -Phenytoin
 Class IC:
 -Flecainide
 -Propafenone
 -Moricizine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: Blocks Na+ channels; greater blockade in tissues already being depolarized; Slows Phase 0 depolarization CLIN: Ventricular arrhythmias
 SE: Lidocaine causes CNS toxicity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Propranolol MECH: Decreases Phase 4 depolarization; decreases HR and contractility
 CLIN: Decreases sudden arrhythmic death Post-MI
 |  | 
        |  | 
        
        | Term 
 
        | What are the Class III Drugs? |  | Definition 
 
        | -Amiodarone -Dronedarone
 -Sotalol
 -Bretylium
 -Ibutilide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: Blocks everything; Increases AP, ERP, QT; reduced ability to respond to tachycardia CLIN: Tx of VT, VF, AFib; prevention of AFib Post-Op
 PHARM-K: Onset 2-3 days; Very long half-life (SE up to 3 months after D/C of drug)
 SE: Vasoconstriction, Brady, Hypotension, Pulmonary symptoms, Hyper/Hypo-Thyroid, Malaise, N/V, Photosensitivity, corneal deposits
 --Should not be given in combo with: Beta-Blockers, diltiazem, verapamil
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PHARM-K: Short half-life CLIN: Similar to Amiodarone but less SE; Tx of AFib
 SE: GI disturbance, Prolonged QT, hepatic failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CLIN: Tx of Sustained VT or VF |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CLIN: Life-threatening ventricular arrhythmias |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CLIN: Chemical cardio-version of AFib and AFlutter |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Diltiazem MECH: Ca++ channel blockers; decrease conduction velocity and increase ERP
 CLIN: Converts AV nodal reentry; Rate controlling drugs for AFib and AFlutter
 SE: Decreased cardiac contractility, decreased AV conduction, Decreased BP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: Slows AV node; Hyperpolarizes the tissue; Reduces Ca++ current PHARM-K: Half-life of seconds
 CLIN: Tx of AV nodal arrhythmias; Diagnostic for AFib/AFlutter
 --Caffeine and Methylxanthines block adenosine effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Digoxin MECH: Selectively and reversibly inhibits the Na+/K+ ATPase ion transport system. Results in rise of intracellular Na+ and Ca++
 PHARM-K: Half-Life 36-40 hrs; Narrow Therapeutic Window: 0.8 - 2.0
 CLIN: CHF - Improves fxn but does not prolong survival
 AFib - Reduces conduction velocity; decreases       refractory period
 SE: Dig Tox: Arrhythmias, N/V, vision disturbance
 --Tx of DigTox: Digibind, correct electrolytes
 |  | 
        |  | 
        
        | Term 
 
        | What are the Beta-Agonist Drugs? |  | Definition 
 
        | -Dobutamine -Dopamine
 -Epinephrine
 -Norepinephrine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: B1>B2 Stimulation B1 Effects: increased contractile force, increased CO
 B2 Effects: Peripheral vasodilation
 CLIN: Acute cardiogenic shock/failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CLIN: Varies By Dosage -0.5-2.0: D1 = Increased Renal and Mesenteric Blood Flow
 -2-10: B1 = Increased Contractility and Increased CO
 -10-20: A and B1 = Predominant A effect and vasoconstriction; Tx of Shock
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CLIN: Varies By Dosage -Low Concentration: B Predominant
 B1 Effect: Increases contractile force, CO, cardiac O2
 B2 Effect: Peripheral vasodilation, Increased skeletal blood flow, bronchial smooth muscle relaxation
 -High Concentration: A1 Predominant
 Vasoconstriction and Anaphylactic Shock
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: A1 = A2 > B1 >> B2; decreased renal blood flow, increased vascular resistance, increased O2 consumption CLIN: Tx of Shock
 SE: reflex brady
 |  | 
        |  | 
        
        | Term 
 
        | Phosphodiesterase Inhibitors |  | Definition 
 
        | Milrinone MECH: Increases cardiac contractility and vasodilation
 CLIN: Short term support for heart failure
 SE: hypotension, ventricular arrhythmias, RENAL DOSING
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Nitroglycerin (NTG) -Isosorbide Dinitrate (ISDN)
 -Isosorbide Mononitrate (ISMN)
 -Sodium Nitroprusside
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: Vascular Smooth Muscle Relaxation PHARM-K: NTG has significant 1st-Pass metabolism; NTG Half-Life - ~1min; ISDN ~1hr; ISMN ~2-4hrs
 Venous dilation > Arterial
 CLIN: Angina, HTN, CHF
 SE: Hypotension, HA, Pts can develop tolerance [Pts should have a "nitrate free interval" - 6-8 hrs]
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH:  Vascular smooth muscle relaxation PHARM-K: Short half-life, continuous infusion required; Arterial and Venous Dilation are EQUAL
 CLIN: Hypertensive Emergency/Urgency, Decompensated Heart failure
 SE: Hypotension and Cyanide poisoning
 |  | 
        |  | 
        
        | Term 
 
        | What are the Phosphodiesterase Inhibitors? |  | Definition 
 
        | -Sildenafil -Vardenafil
 -Tadalafil
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: Penile Erection and some effects in the systemic and pulmonary vasculature CLIN: ED and Pulmonary HTN; Sildenafil can be used for infants with HTN
 SE: HA, flushing, hypotension; ALL are contraindicated with the use of nitrates
 |  | 
        |  | 
        
        | Term 
 
        | What are the Calcium channel blockers? |  | Definition 
 
        | Dihydropyridines: -Amlodipine
 -Felodipine
 -Nifedipine
 
 Non-Dihydropyridines
 -Diltiazem
 -Verapamil
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: Predominantly arteriolar dilators Vasculature: Decreases smooth muscle contractility
 Myocardium: Decreased contractility, decreased SA node pacemaker, decreased AV node conduction
 CLIN: Dihydropyridines: Angina and HTN
 Non-Dihydropyridines: AFlutter/AFib and HTN
 SE: Dihydropiridines: Constipation and Peripheral Edema
 Non-Dihydropiridines: Constipation and Peripheral Edema, Bradycadia and AV block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Minoxidil MECH: Direct arterial vasodilation; smooth muscle contraction inhibited
 CLIN: Refractory HTN, Hypertrichosis
 SE: Na+ and H2O retention (edema); reflex tachy, flushing
 |  | 
        |  | 
        
        | Term 
 
        | Endothelin Receptor Antagonists |  | Definition 
 
        | Bosentan MECH: Competitive antagonist of ETa and ETb; causes vasodilation
 CLIN: Pulmonary HTN
 SE: Hepatic toxicity; teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MECH: Direct arteriolar vasodilation PHARM-K: Frequent dosing (every 6-8 hrs)
 CLIN: HTN and CHF (commonly in combo with a nitrate)
 SE: Lupus-Like syndrome
 |  | 
        |  | 
        
        | Term 
 
        | Beta-Adrenergic Antagonists |  | Definition 
 
        | Labetalol and Carvedilol MECH: Nonselective B1, B2 and A1 receptor blockers
 CLIN: HTN, CHF, AMI
 --All other blockers can work on HTN, but they focus on HR. These two drugs work on vascular tone to reduce BP.
 |  | 
        |  | 
        
        | Term 
 
        | Alpha-Adrenergice Antagonists |  | Definition 
 
        | Prazosin Terazosin
 Doxazosin
 MECH: Selectively block A1 receptors in the arterioles and venules leading to vasodilation
 CLIN: BPH, HTN
 SE: Dizziness, Orthostatic HTN
 |  | 
        |  | 
        
        | Term 
 
        | What are the Four main systems that regulate volume? |  | Definition 
 
        | -Natriuretic Peptides -Renal sympathetic nerves
 -Renin-angiotensin-aldosterone system (RAAS)
 -Antidiuretic Hormone (ADH)
 |  | 
        |  | 
        
        | Term 
 
        | Recombinant Natriuretic Peptide |  | Definition 
 
        | Nesiritide MECH: Causes stimulation of Na+ and H2O loss in kidneys, suppression of thirst, inhibition of antagonistic hormones, dilation of blood vessels
 PHARM-K: Half-Life of 18 min (continuous infusion)
 CLIN: HTN
 SE: Hypotension
 |  | 
        |  | 
        
        | Term 
 
        | What are the ACE Inhibitors? |  | Definition 
 
        | -Captopril -Enalapril
 -Lisinopril
 -Fosinopril
 -Ramipril
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PHARM-K: Pro-drugs requiring hydrolysis for activation; take on an empty stomach CLIN: Heart failure
 SE: Postural hypotension, renal insufficiency, hyperkalemia, angioedema -- stop drug and never start again -- persistent cough, teratogenicity
 |  | 
        |  |